Objectives: To investigate the association between change in daily step count and both adiposity and insulin sensitivity and the extent to which the association between change in daily step count and insulin sensitivity may be mediated by adiposity.
Design: Population based cohort study.
Setting: Tasmania, Australia.
Participants: 592 adults (men (n=267), mean age 51.4 (SD 12.2) years; women (n=325), mean age 50.3 (12.3) years) who participated in the Tasmanian component of the national AusDiab Study in 2000 and 2005.
Main Outcome Measures: Body mass index, waist to hip ratio, and HOMA insulin sensitivity at follow-up in 2005.
Results: Over the five year period, the daily step count decreased for 65% (n=382) of participants. Having a higher daily step count in 2005 than in 2000 was independently associated with lower body mass index (0.08 (95% confidence interval 0.04 to 0.12) lower per 1000 steps), lower waist to hip ratio (0.15 (0.07 to 0.23) lower), and greater insulin sensitivity (1.38 (0.14 to 2.63) HOMA units higher) in 2005. The mean increase in HOMA units fell to 0.34 (-0.79 to 1.47) after adjustment for body mass index in 2005.
Conclusions: Among community dwelling, middle aged adults, a higher daily step count at five year follow-up than at baseline was associated with better insulin sensitivity. This effect seems to be largely mediated through lower adiposity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/bmj.c7249 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Basic Science and Pathogenesis.
Alzheimers Dement
December 2024
CERVO brain research centre, Quebec, QC, Canada.
Background: While individual etiological hypotheses for AD are researched, few large-scale theoretical integrative efforts linking entities involved in these dysfunctions have been attempted. Experimentally, assessing such a global theory is logistically near impossible to achieve as the number of variables is substantial. Alternatively, computational neuroscience allows for the joint study of multiple entities at this scale, the generation of predictions, and their validation with real data.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
Background: Lifetime risk for symptomatic Alzheimer's disease (AD) in people with Down syndrome (DS) is 90%, with the age of onset of symptomatic AD ranging widely. Identifying resiliency factors related to a later age of symptoms is of critical importance for the DS community. This study investigated lifestyle factors hypothesized to moderate the association between amyloid-beta (Aβ plaques) and AD symptoms in adults with DS.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Background: Frontotemporal dementia (FTD) is a common young-onset dementia. Challenges to in-person FTD evaluations (e.g.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Georgia State University, Atlanta, GA, USA.
Background: Beginning new Alzheimer's disease (AD) treatments before AD symptoms are prominent would optimize the benefits of these disease slowing treatments. To accomplish this goal, clinicians must identify measures of early disease progression. As a step in doing this, we set out to characterize the relationships between cognitive complaints, wellbeing, cognitive performance, and metacognitive calibration in older adults in order to inform a model of cognition in typical older adults.
View Article and Find Full Text PDFBackground: Greater physical activity (PA) is associated with better cognitive and vascular health, but accurate assessment of PA is challenging. Self-report questionnaires of PA may be compared against objective measures from smartwatch sensors; the correspondence between measures may be influenced by a variety of factors such as cognition or age. The focus of this study was to identify baseline participant characteristics (vascular risk, cognition) that influence the association between self-reported PA and PA measured with a Garmin Vivosmart 4 smartwatch in a racially diverse sample of older adults.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!